Mercer Global Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,299
| Closed | -$606K | – | 1951 |
|
|
2023
Q1 | $606K | Sell |
26,299
-731
| -3% | -$16.8K | ﹤0.01% | 1108 |
|
|
2022
Q4 | $752K | Buy |
27,030
+821
| +3% | +$22.8K | ﹤0.01% | 1031 |
|
|
2022
Q3 | $804K | Buy |
26,209
+2,346
| +10% | +$72K | ﹤0.01% | 936 |
|
|
2022
Q2 | $702K | Buy |
23,863
+948
| +4% | +$27.9K | ﹤0.01% | 990 |
|
|
2022
Q1 | $737K | Buy |
22,915
+5,563
| +32% | +$179K | ﹤0.01% | 1037 |
|
|
2021
Q4 | $774K | Sell |
17,352
-2,181
| -11% | -$97.3K | ﹤0.01% | 999 |
|
|
2021
Q3 | $985K | Buy |
+19,533
| New | +$985K | 0.01% | 867 |
|